These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 15353985)

  • 1. High incidence of atypical mycobacteriosis in African HIV-infected adults with low CD4 cell counts: a 6-year cohort study in Côte d'Ivoire.
    Bonard D; Messou E; Seyler C; Vincent V; Gabillard D; Anglaret X
    AIDS; 2004 Sep; 18(14):1961-4. PubMed ID: 15353985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AIDS and non-AIDS morbidity and mortality across the spectrum of CD4 cell counts in HIV-infected adults before starting antiretroviral therapy in Cote d'Ivoire.
    Anglaret X; Minga A; Gabillard D; Ouassa T; Messou E; Morris B; Traore M; Coulibaly A; Freedberg KA; Lewden C; Ménan H; Abo Y; Dakoury-Dogbo N; Toure S; Seyler C;
    Clin Infect Dis; 2012 Mar; 54(5):714-23. PubMed ID: 22173233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimates of opportunistic infection incidence or death within specific CD4 strata in HIV-infected patients in Abidjan, Côte d'Ivoire: impact of alternative methods of CD4 count modelling.
    Deuffic-Burban S; Losina E; Wang B; Gabillard D; Messou E; Divi N; Freedberg KA; Anglaret X; Yazdanpanah Y
    Eur J Epidemiol; 2007; 22(10):737-44. PubMed ID: 17828437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The independent effect of highly active antiretroviral therapy on severe opportunistic disease incidence and mortality in HIV-infected adults in Côte d'Ivoire.
    Losina E; Yazdanpanah Y; Deuffic-Burban S; Wang B; Wolf LL; Messou E; Gabillard D; Seyler C; Freedberg KA; Anglaret X
    Antivir Ther; 2007; 12(4):543-51. PubMed ID: 17668563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosed tuberculosis during the follow-up of a cohort of human immunodeficiency virus-infected children in Abidjan, Côte d'Ivoire: ANRS 1278 study.
    Elenga N; Kouakoussui KA; Bonard D; Fassinou P; Anaky MF; Wemin ML; Dick-Amon-Tanoh F; Rouet F; Vincent V; Msellati P
    Pediatr Infect Dis J; 2005 Dec; 24(12):1077-82. PubMed ID: 16371869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of opportunistic diseases on chronic mortality in HIV-infected adults in Côte d'Ivoire.
    Losina E; Anglaret X; Yazdanpanah Y; Wang B; Toure S; Seage GR; N'Dri-Yoman T; Walensky RP; Dakoury-Dogbo N; Goldie SJ; Messou E; Weinstein MC; Deuffic-Burban S; Salamon R; Freedberg KA
    S Afr Med J; 2006 Jun; 96(6):526-9. PubMed ID: 16841136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medium-term survival, morbidity and immunovirological evolution in HIV-infected adults receiving antiretroviral therapy, Abidjan, Côte d'Ivoire.
    Seyler C; Anglaret X; Dakoury-Dogbo N; Messou E; Touré S; Danel C; Diakité N; Daudié A; Inwoley A; Maurice C; Tonwe-Gold B; Rouet F; N'Dri-Yoman T; Salamon R;
    Antivir Ther; 2003 Oct; 8(5):385-93. PubMed ID: 14640385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Profound immunosuppression across the spectrum of opportunistic disease among hospitalized HIV-infected adults in Abidjan, Côte d'Ivoire.
    Grant AD; Djomand G; Smets P; Kadio A; Coulibaly M; Kakou A; Maurice C; Whitaker JP; Sylla-Koko F; Bonard D; Wiktor SZ; Hayes RJ; De Cock KM; Greenberg AE
    AIDS; 1997 Sep; 11(11):1357-64. PubMed ID: 9302446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spectrum of disease among HIV-infected adults hospitalised in a respiratory medicine unit in Abidjan, Côte d'Ivoire.
    Grant AD; Sidibé K; Domoua K; Bonard D; Sylla-Koko F; Dosso M; Yapi A; Maurice C; Whitaker JP; Lucas SB; Hayes RJ; Wiktor SZ; De Cock KM; Greenberg AE
    Int J Tuberc Lung Dis; 1998 Nov; 2(11):926-34. PubMed ID: 9848615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early chemoprophylaxis with trimethoprim-sulphamethoxazole for HIV-1-infected adults in Abidjan, Côte d'Ivoire: a randomised trial. Cotrimo-CI Study Group.
    Anglaret X; Chêne G; Attia A; Toure S; Lafont S; Combe P; Manlan K; N'Dri-Yoman T; Salamon R
    Lancet; 1999 May; 353(9163):1463-8. PubMed ID: 10232311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for active tuberculosis after antiretroviral treatment initiation in Abidjan.
    Seyler C; Toure S; Messou E; Bonard D; Gabillard D; Anglaret X
    Am J Respir Crit Care Med; 2005 Jul; 172(1):123-7. PubMed ID: 15805184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of trimethoprim-sulphamethoxazole prophylaxis to decrease morbidity and mortality in HIV-1-infected patients with tuberculosis in Abidjan, Côte d'Ivoire: a randomised controlled trial.
    Wiktor SZ; Sassan-Morokro M; Grant AD; Abouya L; Karon JM; Maurice C; Djomand G; Ackah A; Domoua K; Kadio A; Yapi A; Combe P; Tossou O; Roels TH; Lackritz EM; Coulibaly D; De Cock KM; Coulibaly IM; Greenberg AE
    Lancet; 1999 May; 353(9163):1469-75. PubMed ID: 10232312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD4+ T Cell Recovery and Hepatitis B Virus Coinfection in HIV-Infected Patients from Côte d'Ivoire Initiating Antiretroviral Therapy.
    Houghtaling L; Moh R; Abdou Chekaraou M; Gabillard D; Anglaret X; Eholié SP; Zoulim F; Danel C; Lacombe K; Boyd A
    AIDS Res Hum Retroviruses; 2018 May; 34(5):439-445. PubMed ID: 29466862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimates of serious fungal infection burden in Côte d'Ivoire and country health profile.
    Koffi D; Bonouman IV; Toure AO; Kouadjo F; N'Gou MRE; Sylla K; Dosso M; Denning DW
    J Mycol Med; 2021 Mar; 31(1):101086. PubMed ID: 33259981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD4-guided structured antiretroviral treatment interruption strategy in HIV-infected adults in west Africa (Trivacan ANRS 1269 trial): a randomised trial.
    Danel C; Moh R; Minga A; Anzian A; Ba-Gomis O; Kanga C; Nzunetu G; Gabillard D; Rouet F; Sorho S; Chaix ML; Eholié S; Menan H; Sauvageot D; Bissagnene E; Salamon R; Anglaret X;
    Lancet; 2006 Jun; 367(9527):1981-9. PubMed ID: 16782488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response to treatment, mortality, and CD4 lymphocyte counts in HIV-infected persons with tuberculosis in Abidjan, Côte d'Ivoire.
    Ackah AN; Coulibaly D; Digbeu H; Diallo K; Vetter KM; Coulibaly IM; Greenberg AE; De Cock KM
    Lancet; 1995 Mar; 345(8950):607-10. PubMed ID: 7898177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreasing incidence of pregnancy by decreasing CD4 cell count in HIV-infected women in Côte d'Ivoire: a 7-year cohort study.
    Loko MA; Toure S; Dakoury-Dogbo N; Gabillard D; Leroy V; Anglaret X
    AIDS; 2005 Mar; 19(4):443-5. PubMed ID: 15750400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short communication: Severe symptomatic hyperlactatemia among HIV type 1-infected adults on antiretroviral therapy in Côte d'Ivoire.
    Minga A; Lewden C; Dohoun L; Abo Y; Emieme A; Coulibaly A; Salamon R; Eholié S; Anglaret X; Danel C;
    AIDS Res Hum Retroviruses; 2010 Sep; 26(9):991-5. PubMed ID: 20707728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of neutropenia in HIV-infected African adults receiving co-trimoxazole prophylaxis: a 6-year cohort study in Abidjan, Côte d'Ivoire.
    Toure S; Gabillard D; Inwoley A; Seyler C; Gourvellec G; Anglaret X
    Trans R Soc Trop Med Hyg; 2006 Aug; 100(8):785-90. PubMed ID: 16458337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morbidity in HIV-1-Infected children treated or not treated with highly active antiretroviral therapy (HAART), Abidjan, Cote d'Ivoire, 2000-04.
    Walenda C; Kouakoussui A; Rouet F; Wemin L; Anaky MF; Msellati P
    J Trop Pediatr; 2009 Jun; 55(3):170-6. PubMed ID: 19066169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.